Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies
This study has been terminated.
( Poor accrual )
Study NCT00943293 Information provided by University of Chicago
First Received on July 20, 2009. Last Updated on July 8, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Preleukemia
Myeloproliferative Disorders
Lymphoma
Myeloma
Graft Versus Host Disease
Additional conditions recognized in this trial
Graft vs Host Disease
Hematologic Neoplasms
Myelodysplastic Syndromes
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Precancerous Conditions
Interventions listed in this trial
Fludarabine
Melphalan
Campath
Additional drug interventions recognized in this trial
Alemtuzumab
Fludarabine monophosphate
More general drug interventions related to this trial
Alkylating Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University of Chicago
Back to top of Main Content
